To understand the posible involement of Kindlin-1 and Kindlin-2 in lung cancer progression, we first examined the expression of Kindlin-1 in lung cancer patient tissues using immnohistochemistry (IHC) with an affinity-purified polyclonal Kindlin-1 antibody, with normal lung tissues as control. This evidence concerns the gene FERMT1 and lung carcinoma.